Vol.
34
No.
8
August 26, 2011Aug 26, 2011
Free

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

Majority of Invasive Bladder Cancer Patients Do Not Receive Full Recommended Care

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

Sentinel Lymph Node Excision Has No Impact on Survival

Increased Breast Density Can Lead to Higher Risk

Computer Interpretation Software Does Not Improve Detection

Bone Marrow Transplant Survival Has Doubled In Young Patients

Two Studies Demonstrate Molecule Blocking Cell Damage

Interim Analysis Suggests Paclical Can Reduce Blood Levels

Hormone Therapy Can Reduce Survival In Men With Heart Problems

Zometa Can Reduce Risk Of Skeletal-Related Events

Cell Phone Radiation Does Not Raise Child’s Risk of Tumors

Clinical Trials Approved by NCI CTEP Last Month

Login